DiaMedica Therapeutics (DMAC) Free Cash Flow: 2018-2019
Historic Free Cash Flow for DiaMedica Therapeutics (DMAC) over the last 2 years, with Dec 2019 value amounting to -$1.9 million.
- DiaMedica Therapeutics' Free Cash Flow rose 0.42% to -$1.9 million in Q4 2019 from the same period last year, while for Dec 2019 it was -$9.1 million, marking a year-over-year decrease of 58.65%. This contributed to the annual value of -$22.1 million for FY2024, which is 17.99% down from last year.
- Per DiaMedica Therapeutics' latest filing, its Free Cash Flow stood at -$1.9 million for Q4 2019, which was down 52.52% from -$1.2 million recorded in Q3 2019.
- DiaMedica Therapeutics' Free Cash Flow's 5-year high stood at -$967,000 during Q1 2018, with a 5-year trough of -$3.1 million in Q1 2019.
- For the 2-year period, DiaMedica Therapeutics' Free Cash Flow averaged around -$1.9 million, with its median value being -$1.9 million (2018).
- Over the last 5 years, DiaMedica Therapeutics' Free Cash Flow had its largest YoY gain of 33.73% in 2019, and its largest YoY loss of 224.10% in 2019.
- DiaMedica Therapeutics' Free Cash Flow (Quarterly) stood at -$1.9 million in 2018, then increased by 0.42% to -$1.9 million in 2019.
- Its last three reported values are -$1.9 million in Q4 2019, -$1.2 million for Q3 2019, and -$2.9 million during Q2 2019.